BeOne Medicines AG
ONC
$315.07
$4.321.39%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 227.36M | 66.50M | 124.84M | 94.32M | 1.27M |
| Total Depreciation and Amortization | 39.40M | 34.44M | 35.75M | 29.87M | 31.63M |
| Total Amortization of Deferred Charges | 1.74M | 1.55M | 1.54M | 5.75M | 1.17M |
| Total Other Non-Cash Items | 121.98M | 151.31M | 140.41M | 128.31M | 88.04M |
| Change in Net Operating Assets | -189.14M | 163.55M | 100.02M | 5.35M | -78.03M |
| Cash from Operations | 201.34M | 417.35M | 402.55M | 263.60M | 44.08M |
| Capital Expenditure | -40.79M | -37.52M | -48.08M | -43.83M | -56.41M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4.72M | -813.00K | -1.19M | -22.78M | -65.53M |
| Cash from Investing | -45.51M | -38.34M | -49.27M | -66.61M | -121.94M |
| Total Debt Issued | 58.20M | 862.74M | 0.00 | 141.52M | 80.00M |
| Total Debt Repaid | -7.64M | -783.62M | -4.26M | -115.45M | -177.14M |
| Issuance of Common Stock | 23.88M | 19.24M | 80.54M | 33.14M | 63.36M |
| Repurchase of Common Stock | -- | 0.00 | 0.00 | -24.20M | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -5.81M | -1.44M | 885.00M | -- | -- |
| Cash from Financing | 68.63M | 96.93M | 961.27M | 35.03M | -33.78M |
| Foreign Exchange rate Adjustments | 19.32M | 23.16M | 9.91M | 23.48M | 3.48M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 243.78M | 499.11M | 1.32B | 255.50M | -108.16M |